City

Condition

Fibrodyplasia Ossificans Progressiva (FOP) (1)

Heterotopic Ossification (HO) (1)

Overall Status

Withdrawn (1)

Sign in for free

Phase

phase 3 (1)

Sponsor

Regeneron Pharmaceuticals (1)

Collaborator

Intervention

garetosmab (1)

Study Documents

Intervention Type

drug (1)

Funder Type

Industry (1)

Study Type

Interventional (1)

fibrodyplasia ossificans progressiva (fop)

Showing 1 - 1 of 1

Trials per page:

STUDY

CONDITIONS

INTERVENTIONS

LOCATIONS

Fibrodyplasia Ossificans Progressiva (FOP), Heterotopic Ossification (HO) Trial (garetosmab)

Withdrawn

Fibrodyplasia Ossificans Progressiva (FOP)
Heterotopic Ossification (HO)

garetosmab

(no location specified)

Oct 25, 2021